Culture-confirmed multidrug-resistant tuberculosis in children: Clinical features, treatment, and outcome

Clinical Infectious Diseases

Volumn 54, Issue 2, 2012, Pages 157-166

  Seddon, James A ^a,b   Hesseling, Anneke C ^a   Willemse, Marianne ^c   Donald, Peter R ^a   Schaaf, H Simon ^a,d  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Brooklyn Hospital for Chest Diseases   (South Africa)

^d STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; CAPREOMYCIN; CLARITHROMYCIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; LINEZOLID; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TERIZIDONE;

ARTICLE; BACTERIUM CULTURE; CHILD; CHILDHOOD MORTALITY; CLINICAL FEATURE; COHORT ANALYSIS; DIRECTLY OBSERVED THERAPY; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MIXED INFECTION; MULTIDRUG RESISTANT TUBERCULOSIS; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SOUTH AFRICA; SPUTUM CULTURE; SPUTUM SMEAR; SURVIVAL; THERAPY DELAY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANALYSIS OF VARIANCE; ANTITUBERCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INFANT; MALE; MYCOBACTERIUM TUBERCULOSIS; RETROSPECTIVE STUDIES; SOUTH AFRICA; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84555204786     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir772     Document Type: Article

References (39)

1. World Health Organization (WHO). Multidrug and extensively drugresistant TB (M/XDR-TB) 2010 Global report on surveillance and response. 2010: (WHO/HTM/TB/2010.3).
2. Orenstein EW, Basu S, Shah NS, et al. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis 2009; 9:153-61.
3. van Rie A, Beyers N, Gie RP, Kunneke M, Zietsman L, Donald PR. Childhood tuberculosis in an urban population in South Africa: burden and risk factor. Arch Dis Child 1999; 80:433-7. (Pubitemid 29220178)
4. Schaaf HS, Shean K, Donald PR. Culture confirmed multidrug resistant tuberculosis: diagnostic delay, clinical features, and outcome. Arch Dis Child 2003; 88:1106-11. (Pubitemid 38064490)
5. Drobac PC, Mukherjee JS, Joseph JK, et al. Community-based therapy for children with multidrug-resistant tuberculosis. Pediatrics 2006; 117:2022-9. (Pubitemid 46071247)
6. Feja K, McNelley E, Tran CS, Burzynski J, Saiman L. Management of pediatric multidrug-resistant tuberculosis and latent tuberculosis infections in New York City from 1995 to 2003. Pediatr Infect Dis J 2008; 27:907-12.
7. Padayatchi N, Bamber S, Dawood H, Bobat R. Multidrug-resistant tuberculous meningitis in children in Durban, South Africa. Pediatr Infect Dis J 2006; 25:147-50. (Pubitemid 43208569)
8. Mendez Echevarria A, Baquero Artigao F, Garcia Miguel MJ, et al. Multidrug-resistant tuberculosis in the pediatric age group. Anales de Pediatria 2007; 67:206-11. (Pubitemid 47394852)
9. Schluger NW, Lawrence RM, McGuiness G, Park M, Rom WN. Multidrug-resistant tuberculosis in children: two cases and a review of the literature. Pediatr Pulmonol 1996; 21:138-42. (Pubitemid 26098519)
10. Suessmuth S, Bange FC, Gappa M. Multidrug resistant tuberculosis in a 6 year old child. Paediatr Respir Rev 2007; 8:265-8. (Pubitemid 47440670)
11. PinonM, Scolfaro C, Bignamini E, et al. Two pediatric cases of multidrugresistant tuberculosis treated with linezolid and moxifloxacin. Pediatrics 2010; 126:e1253-6.
12. Fairlie L, Beylis NC, Reubenson G, Moore DP, Madhi SA. High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study. BMC Infect Dis 2011; 11:28.
13. Thomas TA, Shenoi SV, Heysell SK, et al. Extensively drug-resistant tuberculosis in children with human immunodeficiency virus in rural South Africa. Int J Tuberc Lung Dis 2010; 14:1244-51.
14. Kjollerstrom P, Brito MJ, Gouveia C, Ferreira G, Varandas L. Linezolid in the treatment of multidrug-resistant/extensively drug-resistant tuberculosis in paediatric patients: experience of a paediatric infectious diseases unit. Scand J Infect Dis 2011; 43:556-9.
15. Tochon M, Bosdure E, Salles M, et al. Management of young children in contact with an adult with drug-resistant tuberculosis, France, 2004-2008. Int J Tuberc Lung Dis 2011; 15:326-30.
16. Mukherjee JS, Joseph JK, Rich ML, et al. Clinical and programmatic considerations in the treatment of MDR-TB in children: a series of 16 patients from Lima, Peru. Int J Tuberc Lung Dis 2003; 7:637-44. (Pubitemid 36806858)
17. Beyers N, Gie RP, Schaaf HS, et al. Delay in the diagnosis, notification and initiation of treatment and compliance in children with tuberculosis. Tuber Lung Dis 1994; 75:260-5. (Pubitemid 24270990)
18. Marais BJ, Gie RP, Hesseling AC, et al. A refined symptom-based approach to diagnose pulmonary tuberculosis in children. Pediatrics 2006; 118:e1350-9. (Pubitemid 46394446)
19. Marais BJ, Hesseling AC, Gie RP, Schaaf HS, Enarson DA, Beyers N. The bacteriologic yield in children with intrathoracic tuberculosis. Clin Infect Dis 2006; 42:e69-71.
20. Loebstein R, Koren G. Clinical pharmacology and therapeutic drug monitoring in neonates and children. Pediatr Rev 1998; 19:423-8.
21. Health Systems Trust. Incidence of TB (all types) per 100000. 2009. Available at: http://www.hst.org.za/healthstats/16/data. Accessed 24 February 2011.
22. Schaaf HS, Marais BJ, Hesseling AC, Brittle W, Donald PR. Surveillance of antituberculosis drug resistance among children from the Western Cape Province of South Africa-an upward trend. Am J Public Health 2009; 99:1486-90.
23. Warren RM, Gey van Pittius NC, Barnard M, et al. Differentiation of Mycobacterium tuberculosis complex by PCR amplification of genomic regions of difference. Int J Tuberc Lung Dis 2006; 10:818-22. (Pubitemid 44031399)
24. Schaaf HS, Marais BJ, Whitelaw A, et al. Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases. BMC Infect Dis 2007; 7:140.
25. Schaaf HS, Krook S, Hollemans DW, Warren RM, Donald PR, Hesseling AC. Recurrent culture-confirmed tuberculosis in human immunodeficiency virus-infected children. Pediatr Infect Dis J 2005; 24:685-91. (Pubitemid 41140950)
26. World Health Organization (WHO). Guidelines for the programmatic management of drug-resistant tuberculosis-emergency update. 2008: (WHO/HTM/TB/2008.402).
27. World Health Organization (WHO). Guidance for national tuberculosis programmes on the management of tuberculosis in children. 2006: (WHO/HTM/TB/2006371, WHO/FCH/CAH/20067).
28. Caminero JA, Sotgiu G, Zumla A, Migliori GB. Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. Lancet Infect Dis 2010; 10:621-9.
29. Chiang CY, Schaaf HS. Management of drug-resistant tuberculosis. Int J Tuberc Lung Dis 2010; 14:672-82.
30. Schaaf HS, Marais BJ. Management of multidrug-resistant tuberculosis in children: a survival guide for paediatricians. Paediatr Respir Rev 2011; 12:31-8.
31. Al-Dabbagh M, Lapphra K, McGloin R, et al. Drug-resistant tuberculosis: pediatric guidelines. Pediatr Infect Dis J 2011; 30:501-5.
32. Grant A, Gothard P, Thwaites G. Managing drug resistant tuberculosis. BMJ 2008; 337:a1110.
33. Schaaf HS, Donald PR. The epidemiology and management of drugresistant tuberculosis in childhood. In: Spiegelburg DD, ed. New topics in tuberculosis research. New York, NY: Nova Science Publishers, 2007: 71-102.
34. Schaaf HS, Victor TC, Engelke E, et al. Minimal inhibitory concentration of isoniazid in isoniazid-resistant Mycobacterium tuberculosis isolates from children. Eur J Clin Microbiol Infect Dis 2007; 26:203-5.
35. World Health Organization (WHO). WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva, Switzerland: WHO, 2007.
36. Marais BJ, Gie RP, Schaaf HS, et al. A proposed radiological classification of childhood intra-thoracic tuberculosis. Pediatr Radiol 2004; 34:886-94. (Pubitemid 39462398)
37. World Health Organization (Headquarters and Regional Offices), the International Union Against Tuberculosis and Lung Disease (IUATLD), and the Royal Netherlands Tuberculosis Association (KNCV). Revised international definitions in tuberculosis control. Int J Tuberc Lung Dis 2001; 5:213-5.
38. Hesseling AC, Walzl G, Enarson DA, et al. Baseline sputum time to detection predicts month two culture conversion and relapse in non-HIV-infected patients. Int J Tuberc Lung Dis 2010; 14:560-70.
39. Schaaf HS, Marais BJ, Hesseling AC, Gie RP, Beyers N, Donald PR. Childhood drug-resistant tuberculosis in the Western Cape Province of South Africa. Acta Paediatr 2006; 95:523-8. (Pubitemid 43791572)